1-(p-Hydroxyphenyl)-2-oxo-1-propanol | 35263-55-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(p-Hydroxyphenyl)-2-oxo-1-propanol
• 英文别名: p-Hydroxy-phenylacetylcarbinol；1-hydroxy-1-(4-hydroxy-phenyl)-acetone；1-Hydroxy-1-(4-hydroxy-phenyl)-aceton；1-hydroxy-1-(4-hydroxyphenyl)propan-2-one
• CAS: 35263-55-9
• 化学式: C₉H₁₀O₃
• 分子量: 166.177
• InChiKey: FTNUHCHHYACFSB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(p-Hydroxyphenyl)-2-oxo-1-propanol 生成 1-trimethylsilyloxy-1-(4-trimethylsilyloxyphenyl)propan-2-one
  参考文献：
  名称：

  KRAUS, PUPERT;SPITELLER, GERHARD, PHYTOCHEMISTRY, 29,(1990) N, C. 1653-1659

  摘要：

  DOI：
• 作为产物：
  描述：

  葡萄糖 、 对羟基苯甲醛 在 fermenting brewer's yeast 、 水 作用下， 生成 1-(p-Hydroxyphenyl)-2-oxo-1-propanol
  参考文献：
  名称：

  DE571229

  摘要：

  公开号：

文献信息

• Phenolic compounds from roots of Urtica dioica
  作者：Rupert Kraus、Gerhard Spiteller

  DOI：10.1016/0031-9422(90)80140-c

  日期：1990.1

  Abstract Root extracts from Urtica dioica were separated into several classes of compounds by extraction with organic solvents at different pH values. The phenolic fraction was analysed by GC-MS after trimethylsilylation. This procedure allowed the identification of 18 phenolic compounds as well as the detection of eight lignans. The occurrence of some of these substances in this plant was previously

  摘要 通过用不同pH 值的有机溶剂提取，荨麻根提取物被分离成几类化合物。在三甲基甲硅烷基化后通过 GC-MS 分析酚级分。该程序允许识别 18 种酚类化合物以及检测 8 种木脂素。这些物质中的一些在这种植物中的存在以前是未知的。
• [EN] A NOVEL METHOD FOR SYNTHESIS OF OPTICALLY PURE BETA-AMINO ALCOHOLS<br/>[FR] NOUVEAU PROCÉDÉ DE SYNTHÈSE DE BÊTA-AMINO ALCOOLS OPTIQUEMENT PURS
  申请人：EMBIO LTD

  公开号：WO2015198108A1

  公开（公告）日：2015-12-30

  A method for the preparation of β-amino alcohol of formula (III) in which R1 is Ph, (substituted) Ph, R2 is C1-8 alkyl or C4-6 cyclo alkyl, R3 = R4R5CHNH2 where, R4 = H, C1-8 alkyl, C4-6 cyclo alkyl, or - COOR6 (R6=C1-C8 alkyl); R5 = (subst) aryl], the method including subjecting an α-hydroxy ketone of formula (I) in which R1 and R2 are as defined above is reacted with a chiral amine of formula R3NH2 where R3 = R4R5CH- where, R4 = H, C1-8 alkyl, C4-6 cycloalkyl, or - COOR6 (R6=C1-8 alkyl), R5 = (subst) aryl] to produce a compound of formula (II) in which R1, R2 and R3 are as defined above, followed by reduction to form the compound of formula (III).

  一种制备β-氨基醇的方法，其化学式为(III)，其中R1为苯基、(取代)苯基，R2为C1-8烷基或C4-6环烷基，R3 = R4R5CHNH2，其中，R4 = H、C1-8烷基、C4-6环烷基或-COOR6 (R6=C1-C8烷基)；R5 = (取代)芳基]。该方法包括将化学式为(I)的α-羟基酮，其中R1和R2如上定义，与具有化学式R3NH2的手性胺反应，其中R3 = R4R5CH-，其中，R4 = H、C1-8烷基、C4-6环烷基或-COOR6 (R6=C1-8烷基)，R5 = (取代)芳基]，以生成化学式为(II)的化合物，其中R1、R2和R3如上定义，随后还包括还原以形成化学式为(III)的化合物。
• Cyclic Amine Compounds as CCR5 Antagonists
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1886994A1

  公开（公告）日：2008-02-13

  A compound of the formula: (wherein R1 is a hydrogen atom, a hydrocarbon group which may be substituted, a non-aromatic heterocyclic group which may be substituted, R2 is a hydrocarbon group which may be substituted, a non-aromatic heterocyclic group which may be substituted, or R1 and R2 may combine to each other together with A to form a heterocyclic group which may be substituted; A is N or N+-R5 . Y- (R5 is a hydrocarbon group; Y- is a counter anion) ; R3 is a cyclic hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; n is 0 or 1; R4 is a hydrogen atom, a hydrocarbon group which may be substituted, a heterocyclic group which may be substituted, an alkoxy group which may be substituted, an aryloxy group which may be substituted, or an amino group which may be substituted, E is a divalent aliphatic hydrocarbon group which may be substituted by group (s) other than oxo;G1 is a bond, CO or SO2 ; G2 is CO,S02, NHCO, CONH or OCO ; J is methine or a nitrogen atom; and each of Q and R is a bond or a divalent C1-3 aliphatic hydrocarbon which may be substituted; provided that J is methine when G2 is OCO, that one of Q and R is not a bond when the other is a bond and that each of Q and R is not substituted by oxo group (s) whenGo ils a bond) or a salt thereof has a potent CCR5 antagonistic activity and can be advantageously used for the treatment or prevention of infectious disease of various HIV in humans (e.g. AIDS).

  式中的化合物： (其中 R1 是氢原子、可被取代的烃基、可被取代的非芳香杂环基团，R2 是可被取代的烃基、可被取代的非芳香杂环基团，或 R1 和 R2 可与 A 相互结合形成可被取代的杂环基团；A 是 N 或 N+-R5 .Y-（R5 是烃基；Y- 是反阴离子）；R3 是可被取代的环烃基或可被取代的杂环基；n 是 0 或 1；R4 是氢原子、可被取代的烃基、可被取代的杂环基、可被取代的烷氧基、可被取代的芳氧基或可被取代的氨基；E 是可被除氧代以外的基团（s）取代的二价脂肪族烃基；G1 是键、CO 或 SO2；G2 是 CO、S02、NHCO、CONH 或 OCO；J 是甲烷或氮原子；Q 和 R 各自是键或可被取代的二价 C1-3 脂肪族烃；条件是：当 G2 为 OCO 时，J 为甲烷；当另一个为键时，Q 和 R 中的一个不是键；当 Go ils 为键时，Q 和 R 中的每一个没有被氧化基团（s）取代）或其盐具有强效的 CCR5 拮抗活性，可有利地用于治疗或预防人类各种 HIV 感染性疾病（如艾滋病）。例如艾滋病）。
• EHNOMIYA, TEHJDZI;SIRAISI, YASUSI
  作者：EHNOMIYA, TEHJDZI、SIRAISI, YASUSI

  DOI：——

  日期：——
• EHNOMIYA, TAKUDZI;SIRAISI, YASUSI
  作者：EHNOMIYA, TAKUDZI、SIRAISI, YASUSI

  DOI：——

  日期：——